Krasna M J
Division of Thoracic and Cardiovascular Surgery, University of Maryland School of Medicine, Baltimore 21201, USA.
Chest. 1998 Jan;113(1 Suppl):107S-111S. doi: 10.1378/chest.113.1_supplement.107s.
Staging criteria for thoracic malignancies are based on survival groupings that allow the stage groups to be used as prognosticators for cancer treatment. Definitive staging of esophageal cancer facilitates allocation of patients to appropriate treatment regimens according to each patient's stage. Existing noninvasive staging methods are imperfect in detecting abdominal and thoracic lymph node metastases in patients with esophageal cancer. Thoracoscopy is an excellent means for staging the chest and mediastinum. We have used thoracoscopic lymph node staging and laparoscopic lymph node staging for esophageal cancer since 1992. Thoracoscopy was performed in 45 patients with biopsy specimen-proved carcinoma of the esophagus. Laparoscopy was done in the last 20 patients. Laparoscopic-assisted feeding jejunostomies were performed in patients with obstructive symptoms. Directed liver biopsies were performed if lesions were present. Thoracoscopy was aborted in three patients because of adhesions. Thoracic lymph node stage was N0 in 40 patients and N1 in 3. Celiac lymph nodes were normal in 14 patients and abnormal in 6. Esophageal resection was performed in 30 patients after thoracoscopic lymph node staging; 18 of these underwent laparoscopic lymph node staging. Thoracoscopic staging showed N0 lymph node status in 28 patients and N1 in 2. Two of these N0 patients (7%) were found at resection to have paraesophageal lymph involvement (N1). Thoracoscopic lymph node staging was accurate in detecting the status of thoracic lymph nodes in 28 of 30 cases (93%). Laparoscopic staging found normal celiac nodes in 13 patients and abnormal lymph nodes in 5. After esophagectomy, final pathologic finding of the 13 N0 patients was N0 in 12 patients and N1 in 1 patient. Thus, laparoscopic lymph node staging was accurate in detecting lymph node status in 17 of 18 patients (94%). Six of 20 patients undergoing laparoscopy had unsuspected celiac axis lymph node involvement missed by standard noninvasive techniques. Three percent of thoracic lymph nodes and 17% of celiac lymph nodes were downstaged after preoperative chemoradiotherapy. Thoracoscopic and laparoscopic lymph node staging are more accurate than existing staging methods.
胸段恶性肿瘤的分期标准基于生存分组,这些分组使分期组能够用作癌症治疗的预后指标。食管癌的明确分期有助于根据每位患者的分期将其分配到合适的治疗方案。现有的非侵入性分期方法在检测食管癌患者的腹部和胸部淋巴结转移方面并不完善。胸腔镜检查是对胸部和纵隔进行分期的极佳手段。自1992年以来,我们一直使用胸腔镜淋巴结分期和腹腔镜淋巴结分期来评估食管癌。对45例经活检标本证实为食管癌的患者进行了胸腔镜检查。对最后20例患者进行了腹腔镜检查。对有梗阻症状的患者进行了腹腔镜辅助空肠造口术。如果存在病变,则进行定向肝活检。3例患者因粘连而中止了胸腔镜检查。40例患者的胸段淋巴结分期为N0,3例为N1。14例患者的腹腔淋巴结正常,6例异常。30例患者在胸腔镜淋巴结分期后进行了食管切除术;其中18例接受了腹腔镜淋巴结分期。胸腔镜分期显示28例患者的淋巴结状态为N0,2例为N1。这28例N0患者中有2例(7%)在切除时发现有食管旁淋巴结受累(N1)。胸腔镜淋巴结分期在30例中的28例(93%)中准确检测到了胸段淋巴结的状态。腹腔镜分期发现13例患者的腹腔淋巴结正常,5例异常。食管切除术后,13例N0患者的最终病理结果为12例N0,1例N1。因此,腹腔镜淋巴结分期在18例患者中的17例(94%)中准确检测到了淋巴结状态。20例接受腹腔镜检查的患者中有6例存在标准非侵入性技术漏诊的腹腔动脉淋巴结受累。术前放化疗后,3%的胸段淋巴结和17%的腹腔淋巴结分期降低。胸腔镜和腹腔镜淋巴结分期比现有的分期方法更准确。